-

Shareholder Alert: The Ademi Firm Investigates Whether PharmChem, Inc. is Obtaining a Fair Price for its Public Shareholders

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating PharmChem (OTC: PCHM) for possible breaches of fiduciary duty and other violations of law in its transaction with Alcohol Monitoring Systems.

Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you.

In the transaction, shareholders of PharmChem will receive $3.75 per share in cash. PharmChem insiders will receive substantial benefits as part of change of control arrangements.

The transaction agreement unreasonably limits competing transactions for PharmChem by imposing a significant penalty if PharmChem accepts a competing bid. We are investigating the conduct of the PharmChem board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi & Fruchter LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

Industry:

Ademi & Fruchter LLP

OTC Pink:PCHM
Release Versions
English

Contacts

Ademi & Fruchter LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

More News From Ademi & Fruchter LLP

Shareholder Alert: The Ademi Firm Investigates Whether Core Scientific, Inc. Is Obtaining a Fair Price for Its Public Shareholders

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Core Scientific (NYSE: CORZ) for possible breaches of fiduciary duty and other violations of law in its transaction with CoreWeave. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shareholders of Core Scientific will receive 0.1235 newly issued shares of CoreWeave Class A common...

Shareholder Alert: The Ademi Firm Investigates Whether Olo Inc. Is Obtaining a Fair Price for Its Public Shareholders

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Olo (NYSE: OLO) for possible breaches of fiduciary duty and other violations of law in its transaction with Thoma Bravo. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shareholders of Olo will receive $10.25 per share, valuing Olo at approximately $2.0 billion in equity value....

Shareholder Alert: The Ademi Firm Investigates Whether Steelcase Inc. Is Obtaining a Fair Price for Its Public Shareholders

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Steelcase (NYSE: SCS) for possible breaches of fiduciary duty and other violations of law in its transaction with HNI Corporation. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shareholders of Steelcase will receive $7.20 in cash and 0.2192 shares of HNI common stock for each...
Back to Newsroom